- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07942337
Comparison of the Effects of Vibration and Non-Vibration Foam Rolling on Post-Exercise Recovery
Comparison of the Effects of Vibration and Non-Vibration Foam Rolling on Post-Exercise Recovery in Recreational Athletes: A Randomized Controlled Trial
This project/research is supported within the scope of the "2209-A University Students Research Projects Support Program" 2025/1 term conducted by the Scientific and Technological Research Council of Türkiye (TÜBİTAK) Scientist Support Programs Directorate (BİDEB).
The post-exercise recovery process in athletes is a critical process in terms of the sustainability of performance, the effectiveness of physiological adaptation, and the prevention of overload-related injuries. Microtraumatic damage occurring in muscle tissue during exercise, depletion of energy stores, and neuromechanical fatigue lead to disruption of homeostatic balance. Therefore, the effectiveness of recovery is a determining factor both in maintaining performance and sustaining musculoskeletal health. In the literature, it has been demonstrated that in the absence of appropriate recovery strategies, the risk of injury increases due to reductions in the viscoelastic properties of the muscle-tendon complex and deterioration in proprioceptive control.
In recent years, vibrating foam roller applications have attracted attention among innovative approaches supporting recovery. While the conventional foam roller supports recovery by reducing muscle tone and increasing blood flow, the vibrating version has been suggested to accelerate neuromuscular relaxation by enhancing proprioceptive feedback. However, the current evidence regarding the effects of this method is limited, and most studies have focused only on acute outcomes. This project aims to comparatively investigate the short- and mid-term effects of vibrating and non-vibrating foam roller applications on recovery in young-adult athletes with exercise-induced muscle damage.
Athletes included in the project will be randomly assigned into two groups after delayed onset muscle soreness (DOMS) is induced in the gastrocnemius muscle through a standardized eccentric plantar flexion protocol. Group 1 will receive a vibrating foam roller application, whereas Group 2 will receive a non-vibrating foam roller application. The level of delayed onset muscle soreness (DOMS) will be assessed using the Visual Analog Scale (VAS) immediately after the application, at 24 hours, 48 hours, and at the end of the first week. In addition, the passive mechanical properties of the muscle related to the recovery process will be evaluated non-invasively from the gastrocnemius muscle using the MyotonPRO device. Data will be analyzed using a Two-Way Repeated Measures ANOVA to examine the interaction between time and group factors. Sample size was determined as 40 participants with 80% power using G*Power software.
The project will be conducted by a team experienced in the field of sports physiotherapy, and the processes of data collection, analysis, and reporting will be planned in accordance with the research timeline. It is anticipated that the findings obtained will contribute to the development of an evidence-based and low-cost recovery method in the field of sports physiotherapy.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Niğde, Turkey (Türkiye)
- Niğde Ömer Halisdemir University, Faculty of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Having at least 5 years of sports experience.
- Training at least 2 days per week.
- Being between 18 and 35 years of age.
Exclusion Criteria:
- Having any active injury.
- Being unable to complete the muscle damage protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Vibration Foam Rolling (VFR) Group
|
Participants will receive foam rolling with the vibration function activated. The intervention will be applied to the posterior calf muscles for three 60-second sets per leg, with 30-second rest intervals between sets. |
|
Active Comparator: Non-Vibration Foam Rolling (FR) Group
|
Participants will receive foam rolling using the same device with the vibration function deactivated. The intervention will be applied to the posterior calf muscles for three 60-second sets per leg, with 30-second rest intervals between sets. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Delayed-Onset Muscle Soreness (DOMS) Intensity Assessed Using the Visual Analog Scale (VAS)
Time Frame: Baseline (pre-intervention), immediately post-intervention, and at 24 hours, 48 hours, and 1 week post-intervention.
|
Muscle soreness intensity will be assessed using the Visual Analog Scale (VAS), with scores ranging from 0 (no soreness) to 10 (worst imaginable soreness). Higher scores indicate greater muscle soreness intensity. |
Baseline (pre-intervention), immediately post-intervention, and at 24 hours, 48 hours, and 1 week post-intervention.
|
|
Delayed-Onset Muscle Soreness (DOMS) Severity Assessed Using the 7-Point Likert Scale of Muscle Soreness
Time Frame: Baseline (pre-intervention), immediately post-intervention, and at 24 hours, 48 hours, and 1 week post-intervention.
|
Muscle soreness severity will be assessed using the 7-Point Likert Scale of Muscle Soreness. Higher scores indicate greater muscle soreness severity. |
Baseline (pre-intervention), immediately post-intervention, and at 24 hours, 48 hours, and 1 week post-intervention.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2209-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.